Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DR26FBYLL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,960
Award facts
- Contract value 100% obligated
- $4,960.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,960.06 by the Defense Logistics Agency for 68 mg Nexplanon implants, with an ultimate completion date of November 26, 2025. This firm fixed-price delivery order was issued without a set-aside designation, reflecting the company's competitive capability in unrestricted federal procurement. The award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which carries a $499.999 billion ceiling value and extends through December 31, 2036.
The PPV-G GEN V contract positions DMS Pharmaceutical Group as a regional prime vendor contractor within the Department of Defense's broader $30.3 billion pharmaceutical supply strategy, authorizing the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products including prescription drugs, biologics, and medical consumables to support military healthcare facilities worldwide. This delivery order for Nexplanon implants exemplifies the company's established role as a critical supplier within the federal military medical system, with the company demonstrating substantial performance across diverse therapeutic categories and product lines throughout its engagement with Defense Logistics Agency's Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DR26FBYLL?
SPE2DR26FBYLL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FBYLL worth?
The government has obligated $4,960 on SPE2DR26FBYLL.
Is contract SPE2DR26FBYLL an order under another contract?
Yes. SPE2DR26FBYLL is a delivery order under SPE2DR25D9103, an indefinite delivery contract.
Was contract SPE2DR26FBYLL competed?
The extent of competition for SPE2DR26FBYLL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award